Small molecules in the treatment of COVID-19
S Lei, X Chen, J Wu, X Duan, K Men - Signal transduction and targeted …, 2022 - nature.com
The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to
societies and economies. Until now, effective therapeutics against COVID-19 are in high …
societies and economies. Until now, effective therapeutics against COVID-19 are in high …
Effects of COVID‐19 vaccination during pregnancy on SARS‐CoV‐2 infection and maternal and neonatal outcomes: A systematic review and meta‐analysis
SARS‐CoV‐2 infection during pregnancy is associated with adverse maternal and neonatal
outcomes, but no systematic synthesis of evidence on COVID‐19 vaccination during …
outcomes, but no systematic synthesis of evidence on COVID‐19 vaccination during …
Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies
Monkeypox is a rare zoonotic disease caused by infection with the monkeypox virus. The
disease can result in flu‐like symptoms, fever, and a persistent rash. The disease is currently …
disease can result in flu‐like symptoms, fever, and a persistent rash. The disease is currently …
[HTML][HTML] A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
Efficacy and safety of tixagevimab‐cilgavimab as pre‐exposure prophylaxis for COVID‐19: a systematic review and meta‐analysis
Some proportions of populations, such as immunocompromised patients and organ
transplant recipients might have inadequate immune responses to the vaccine for …
transplant recipients might have inadequate immune responses to the vaccine for …
Insight into the role of clathrin‐mediated endocytosis inhibitors in SARS‐CoV‐2 infection
Emergence of SARS‐CoV‐2 variants warrants sustainable efforts to upgrade both the
diagnostic and therapeutic protocols. Understanding the details of cellular and molecular …
diagnostic and therapeutic protocols. Understanding the details of cellular and molecular …
Quercetin for the treatment of COVID‐19 patients: a systematic review and meta‐analysis
HA Cheema, A Sohail, A Fatima… - Reviews in Medical …, 2023 - Wiley Online Library
Currently approved therapies for COVID‐19 are mostly limited by their low availability, high
costs or the requirement of parenteral administration by trained medical personnel in an in …
costs or the requirement of parenteral administration by trained medical personnel in an in …
Antiviral molecular targets of essential oils against SARS-CoV-2: A systematic review
Essential oils are potential therapeutics for coronavirus disease 2019 (COVID-19), in which
some of the volatile compounds of essential oils have been well known for their broad …
some of the volatile compounds of essential oils have been well known for their broad …
COVID-19 drug discovery and treatment options
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and …
Repurposing molnupiravir for COVID-19: the mechanisms of antiviral activity
Molnupiravir is a β-d-N4-hydroxycytidine-5′-isopropyl ester (NHC) compound that exerts
antiviral activity against various RNA viruses such as influenza, SARS, and Ebola viruses …
antiviral activity against various RNA viruses such as influenza, SARS, and Ebola viruses …